Janux Therapeutics, Inc. - Common Stock (JANX)
CUSIP: 47103J105
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 60,117,449
- Total 13F shares
- 65,065,945
- Share change
- -280,483
- Total reported value
- $1,590,036,358
- Put/Call ratio
- 36%
- Price per share
- $24.44
- Number of holders
- 170
- Value change
- -$3,819,977
- Number of buys
- 78
- Number of sells
- 84
Quarterly Holders Quick Answers
What is CUSIP 47103J105?
CUSIP 47103J105 identifies JANX - Janux Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 47103J105:
Top shareholders of JANX - Janux Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13D/G
3/4/5
13F
|
Director, 10%+ Owner · Company |
20%
|
11,971,377
|
$383,922,060 | $0 | 06 Mar 2025 | |
| Avalon Ventures XI, L.P. |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
7,383,837
mixed-class rows
|
$346,500,118 | — | 16 Oct 2024 | |
| Jay B. Lichter |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
6,568,498
mixed-class rows
|
$293,610,026 | — | 13 Sep 2024 | |
| Tighe Reardon |
3/4/5
|
Acting Chief Financial Officer |
—
mixed-class rows
|
4,305,680
mixed-class rows
|
$227,140,231 | — | 03 Jun 2024 | |
| FMR LLC |
13F
|
Company |
15%
|
8,888,742
|
$205,329,932 | — | 30 Jun 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
7.4%
|
4,460,332
|
$103,045,329 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
5.7%
from 13D/G
|
3,402,847
|
$78,605,766 | — | 30 Jun 2025 | |
| Paradigm Biocapital Advisors LP |
13D/G
13F
|
Company |
4.9%
|
2,920,258
|
$73,444,489 | -$14,982,559 | 30 Jun 2025 | |
| Adage Capital Management, L.P. |
13D/G
|
— |
4.3%
|
2,525,000
|
$63,503,750 | -$13,499,262 | 30 Jun 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
4.2%
|
2,525,000
|
$58,327,500 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.6%
|
2,189,428
|
$50,575,788 | — | 30 Jun 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
3.6%
|
2,143,900
|
$49,524,090 | — | 30 Jun 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
3%
|
1,793,427
|
$41,429,000 | — | 30 Jun 2025 | |
| Cormorant Asset Management, LP |
13F
|
Company |
2.5%
|
1,500,000
|
$34,650,000 | — | 30 Jun 2025 | |
| EcoR1 Capital, LLC |
13F
|
Company |
2.4%
|
1,469,818
|
$33,952,796 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.3%
|
1,388,108
|
$32,065,295 | — | 30 Jun 2025 | |
| Woodline Partners LP |
13F
|
Company |
2.1%
|
1,241,938
|
$28,688,768 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2%
|
1,231,126
|
$28,439,011 | — | 30 Jun 2025 | |
| ORBIMED ADVISORS LLC |
13F
3/4/5
|
Company · Director |
2%
|
1,210,300
|
$27,957,930 | — | 30 Jun 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.8%
|
1,069,195
|
$24,698,414 | — | 30 Jun 2025 | |
| Logos Global Management LP |
13F
|
Company |
1.7%
|
1,000,000
|
$23,100,000 | — | 30 Jun 2025 | |
| Bregua Corp |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,749,250
|
$22,008,098 | — | 15 Jun 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
902,312
|
$20,845,366 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.4%
|
859,423
|
$19,852,670 | — | 30 Jun 2025 | |
| Prosight Management, LP |
13F
|
Company |
1.4%
|
853,904
|
$19,725,182 | — | 30 Jun 2025 | |
| READYSTATE ASSET MANAGEMENT LP |
13F
|
Company |
1.2%
|
695,956
|
$16,076,584 | — | 30 Jun 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1.1%
|
671,485
|
$15,511,304 | — | 30 Jun 2025 | |
| MPM BioImpact LLC |
13F
|
Company |
1%
|
614,282
|
$14,189,914 | — | 30 Jun 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.82%
|
492,361
|
$11,373,539 | — | 30 Jun 2025 | |
| Caption Management, LLC |
13F
|
Company |
0.76%
|
457,012
|
$10,556,977 | — | 30 Jun 2025 | |
| First Turn Management, LLC |
13F
|
Company |
0.74%
|
447,420
|
$10,335,402 | — | 30 Jun 2025 | |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. |
13F
|
Company |
0.63%
|
376,496
|
$8,697,058 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.58%
|
348,490
|
$8,050,119 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.57%
|
341,842
|
$7,896,551 | — | 30 Jun 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.56%
|
333,752
|
$7,710,000 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.53%
|
315,731
|
$7,293,400 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.5%
|
299,377
|
$6,915,609 | — | 30 Jun 2025 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.49%
|
292,686
|
$6,761,047 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.49%
|
292,533
|
$6,757,513 | — | 30 Jun 2025 | |
| Aberdeen Group plc |
13F
|
Company |
0.47%
|
285,288
|
$6,590,153 | — | 30 Jun 2025 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.43%
|
258,678
|
$5,975,462 | — | 30 Jun 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.43%
|
255,585
|
$5,904,039 | — | 30 Jun 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.41%
|
247,873
|
$5,725,866 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.41%
|
247,424
|
$5,715,495 | — | 30 Jun 2025 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.41%
|
246,916
|
$5,703,760 | — | 30 Jun 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.38%
|
229,989
|
$5,312,746 | — | 30 Jun 2025 | |
| Jump Financial, LLC |
13F
|
Company |
0.38%
|
228,430
|
$5,276,733 | — | 30 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.36%
|
214,362
|
$4,951,762 | — | 30 Jun 2025 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.35%
|
210,266
|
$4,857,145 | — | 30 Jun 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.33%
|
200,000
|
$4,620,000 | — | 30 Jun 2025 |
Institutional Holders of Janux Therapeutics, Inc. - Common Stock (JANX) as of Q3 2025
As of 30 Sep 2025,
Janux Therapeutics, Inc. - Common Stock (JANX) was held by
170 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
65,065,945 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., FMR LLC, JANUS HENDERSON GROUP PLC, BlackRock, Inc., Paradigm Biocapital Advisors LP, ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, STATE STREET CORP, ORBIMED ADVISORS LLC, and Point72 Asset Management, L.P..
This page lists
170
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
169
Q3 2025 holders
170
Holder diff
1
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.